2023. Pharmacological blockade of protease-Activated Receptor 2 improves airway remodeling and lung inflammation in experimental allergic asthma. Brazilian Journal of Pharmaceutical Sciences. 58, (Feb. 2023). DOI:https://doi.org/10.1590/s2175-97902022e201089.